عنوان

Platelet glycoprotein IIb/IIIa inhibitors in cardiovascular disease /

(Number (ISBN

147576202X

(Number (ISBN

1592597246

(Number (ISBN

9781475762020

(Number (ISBN

9781592597246

Erroneous ISBN

0896037274

Erroneous ISBN

9780896037274

Number

b797537

Title Proper

Platelet glycoprotein IIb/IIIa inhibitors in cardiovascular disease /

General Material Designation

[Book]

First Statement of Responsibility

edited by A. Michael Lincoff, Eric J. Topol.

Place of Publication, Distribution, etc.

Totowa, N.J. :

Name of Publisher, Distributor, etc.

Humana Press,

Date of Publication, Distribution, etc.

©1999.

Specific Material Designation and Extent of Item

1 online resource (xiv, 368 pages) :

Other Physical Details

illustrations, portraits

Series Title

Contemporary cardiology

Text of Note

Includes bibliographical references and index.

Text of Note

I Basic Principles -- 1 Thrombosis in Acute Coronary Syndromes and Coronary Interventions -- 2 Mechanisms of Platelet Adhesion -- 3 Glycoprotein IIb-IIIA in Platelet Aggregation and Acute Arterial Thrombosis -- 4 Glycoprotein IIb/IIIa Antagonists: Development of Abciximab and Pharmacology of Select Agents -- II Glycoprotein IIB/IIIA Blockade During Coronary Intervention -- 5 Abciximab in Coronary Intervention -- The EPIC, EPILOG, EPISTENT Trials -- 6 Eptifibatide in Coronary Intervention -- The IMPACT Trials -- 7 Tirofiban in Coronary Intervention -- The RESTORE Trial -- 8 The Use of Abciximab in Therapy Resistant Unstable Angina: Clinical and Angiographic Results of the CAPTURE Pilot and the CAPTURE Study -- 9 Overview of the Glycoprotein IIb/IIIa Inhibitor Interventional Trials -- III Glycoprotein IIb/IIIa Blockade for Ischemic Syndromes -- 10 Unstable Angina: PURSUIT, PARAGON, PRISM, and PRISM PLUS -- 11 The Use of Glycoprotein IIb/IIIa Inhibition in Acute Myocardial Infarction -- IV Practical Issues and Future Applications -- 12 Economics of Glycoprotein IIb/IIIa Inhibition -- 13 Monitoring Platelet Aggregation -- 14 Oral Platelet Glycoprotein IIb/IIIa Blockade -- 15 Cerebrovascular Aspects of Glycoprotein IIb/IIIa Inhibitors -- 16 The Future of Glycoprotein IIb/IIIa Inhibitors.

0

Text of Note

In Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, the major investigators working in this rapidly advancing field join together under the aegis of A. Michael Lincoff and Eric J. Topol to provide the first comprehensive overview of the preclinical and clinical development of the glycoprotein IIb/IIIa receptor antagonists. These acknowledged experts elucidate the theoretical basis for the inhibition of platelet aggregation in the treatment of coronary syndromes, present and synthesize evidence for the efficacy of glycoprotein IIb/IIIa blockade in inhibiting ischemic complications of both coronary intervention and acute coronary syndromes, and provide guidelines for the use of this novel class of agents in the clinical management of cardiovascular disease. They also compare the pharmacology and clinical efficacy of the currently available glycoprotein IIb/IIIa receptor inhibitors and speculate about further potential applications of these agents in the treatment of vascular disease. Written by the scientists and physicians who discovered and characterized this important new class of receptors, invented the first IIb/IIIa agents, and conducted the definitive clinical trials, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease offers the most complete and authoritative review of these powerful new therapeutics available today.

Text of Note

Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.

Title

Platelet glycoprotein IIb/IIIa inhibitors in cardiovascular disease.

International Standard Book Number

9780896037274

Blood platelets-- Aggregation.

Coronary heart disease-- Chemotherapy.

Coronary heart disease-- Pathophysiology.

Platelet glycoprotein GPIIb-IIIa complex-- Inhibitors-- Therapeutic use-- Testing.

Cardiovascular Diseases-- drug therapy.

Platelet Glycoprotein GPIIb-IIIa Complex-- therapeutic use.

Blood platelets-- Aggregation.

Coronary heart disease-- Chemotherapy.

Coronary heart disease-- Pathophysiology.

MEDICAL-- Cardiology.

MED-- 010000

MJD

MJD

Number

Edition

Class number

Book number

Class number

Class number

Book Number

Lincoff, A. Michael.

Topol, Eric J.,1954-

Date of Transaction

20201207101433.0

Cataloguing Rules (Descriptive Conventions))

pn

Electronic name

[Book]

Y